The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Tumor Necrosis Factor and Granulocyte Macrophage-Colony Stimulating Factor Stimulate Human Macrophages to Restrict Growth of Virulent Mycobacterium avium and to Kill Avirulent M. avium: Killing Effector Mechanism Depends on the Generation of Reactive Nitrogen Intermediates
Abstract
An avirulent and a virulent strain of Mycobacterium avium were selected on the basis of their growth patterns in human monocyte-derived macrophages. The virulent 7497 M. avium grew progressively in untreated macrophages, whereas the avirulent LR/149 M. avium was killed to a moderate extent by untreated human macrophages (50% of the original infectious inoculum killed 7 days after infection). We set out to investigate the possibility of modulating these growth patterns by cytokine treatment. Application of tumor necrosis factor (TNF) (100 U/ml) led to macrophages restricting significantly the growth of virulent M. avium 7497 (tenfold decrease at 7 days). TNF was also effective at modulating positively the interaction between avirulent LR/149 M. avium and macrophages inasmuch as TNF-treated cells killed 99% of infecting mycobacteria at 7 days. Granulocyte macrophage-colony stimulating factor (GM-CSF) (100–10,000 U/ml) treatment led to macrophages being as mycobacteriostatic for virulent 7497 M. avium as TNF-α-treated cells (i.e., tenfold reduction in growth). Treatment of macrophages with both GM-CSF and TNF-α was shown to have additive effects on bacteriostatic activity on M. avium. The mechanism of killing of avirulent M. avium by TNF-α was shown to be dependent on the generation of reactive nitrogen intermediates, as seen by inhibition of effector mechanisms by NG-monomethyl-arginine and arginase. Moreover, there was a correlation between NO2– generation and mycobactericidal activity of macrophages. Addition of superoxide dismutase reversed the killing of avirulent M. avium by untreated or TNF-treated macrophages. This abrogation was also apparent in chronic granulomatous disease (CGD) macrophages, which were inefficient at generating reactive oxygen intermediates. Moreover, macrophages from CGD patients killed avirulent M. avium as efficiently as cells from normal individuals. We conclude from these results that 1) GM-CSF and TNF-α, alone or in combination, increase effector functions of macrophages against virulent and avirulent strains of M. avium; 2) reactive nitrogen intermediates seem to be involved in this effector mechanism; and 3) superoxide dismutase protected M. avium against macrophage effector function, seemingly by protecting the bacteria against endogenous superoxide anion. The implications of these findings for host resistance to atypical mycobacteria are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids
Green, L. C., Wagner, D. A., Glogowski, J., Skipper, P. L., Wishnok, J. S., & Tannenbaum, S. R. (1982) · Analytical Biochemistry · doi:10.1016/0003-2697(82)90118-x · Cited by 12,077
Ding, A. H., Nathan, C. F., & Stuehr, D. J. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.7.2407 · Cited by 2,826
Stuehr, D. J., & Nathan, C. F. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.169.5.1543 · Cited by 1,744
Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate
Marletta, M. A., Yoon, P. S., Iyengar, R., Leaf, C. D., & Wishnok, J. S. (1988) · Biochemistry · doi:10.1021/bi00424a003 · Cited by 1,600
Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite
Hibbs, J. B., Taintor, R. R., & Vavrin, Z. (1987) · Science · doi:10.1126/science.2432665 · Cited by 1,527
Kindler, V., Sappino, A.-P., Grau, G. E., Piguet, P.-F., & Vassalli, P. (1989) · Cell · doi:10.1016/0092-8674(89)90676-4 · Cited by 1,254
Infection with Mycobacterium avium Complex in Patients without Predisposing Conditions
Prince, D. S., Peterson, D. D., Steiner, R. M., Gottlieb, J. E., Scott, R., Israel, H. L., Figueroa, W. G., & Fish, J. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198909283211304 · Cited by 688
Green, S. J., Meltzer, M. S., Hibbs, J. B., & Nacy, C. A. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.1.278 · Cited by 675
Bermudez, L. E. M., & Young, L. S. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.9.3006 · Cited by 378
Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages.
Granger, D. L., Hibbs, J. B., Perfect, J. R., & Durack, D. T. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113427 · Cited by 328
Cited by
The L-Arginine-Nitric Oxide Pathway
Epstein, F. H., Moncada, S., & Higgs, A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292706 · Cited by 6,678
Nitric oxide as a secretory product of mammalian cells
Nathan, C. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.12.1381691 · Cited by 4,350
NITRIC OXIDE AND MACROPHAGE FUNCTION
MacMicking, J., Xie, Q.-W., & Nathan, C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.323 · Cited by 4,211
Interferon-γ: an overview of signals, mechanisms and functions
Schroder, K., Hertzog, P. J., Ravasi, T., & Hume, D. A. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0603252 · Cited by 4,120
Identification of nitric oxide synthase as a protective locus against tuberculosis
MacMicking, J. D., North, R. J., LaCourse, R., Mudgett, J. S., Shah, S. K., & Nathan, C. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5243 · Cited by 1,180
Mammalian nitric oxide synthases
Stuehr, D. J. (1999) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(99)00016-x · Cited by 996
Inflammation, immunoregulation, and inducible nitric oxide synthase
Nussler, A. K., & Billiar, T. R. (1993) · Journal of Leukocyte Biology · doi:10.1002/jlb.54.2.171 · Cited by 860
Nitric Oxide Synthase in Human and Rat Lung: Immunocytochemical and Histochemical Localization
Kobzik, L., Bredt, D. S., Lowenstein, C. J., Drazen, J., Gaston, B., Sugarbaker, D., & Stamler, J. S. (1993) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb/9.4.371 · Cited by 810
Endogenous nitric oxide: physiology, pathology and clinical relevance
MONCADA, S., & HIGGS, E. A. (1991) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1991.tb01383.x · Cited by 759
Gardam, M. A., Keystone, E. C., Menzies, R., Manners, S., Skamene, E., Long, R., & Vinh, D. C. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00545-0 · Cited by 752
The Mycobacterium avium complex
Inderlied, C. B., Kemper, C. A., & Bermudez, L. E. (1993) · Clinical Microbiology Reviews · doi:10.1128/cmr.6.3.266 · Cited by 687
Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases
Lucey, D. R., Clerici, M., & Shearer, G. M. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.4.532 · Cited by 666
Benjamin, N., O'Driscoll, F., Dougall, H., Duncan, C., Smith, L., Golden, M., & McKenzie, H. (1994) · Nature · doi:10.1038/368502a0 · Cited by 665
The 1991 Ulf von Euler Lecture:The l‐arginine: nitric oxide pathway
MONCADA, S. (1992) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1992.tb09359.x · Cited by 645
Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways.
Gaston, B., Reilly, J., Drazen, J. M., Fackler, J., Ramdev, P., Arnelle, D., Mullins, M. E., Sugarbaker, D. J., Chee, C., Singel, D. J., et al. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.10957 · Cited by 623
Haddad, I. Y., Pataki, G., Hu, P., Galliani, C., Beckman, J. S., & Matalon, S. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117607 · Cited by 594
Inducible nitric oxide synthase in human diseases
Kröncke, K.-D., Fehsel, K., & Kolb-Bachofen, V (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1998.00648.x · Cited by 585
Role of oxidants in microbial pathophysiology
Miller, R. A., & Britigan, B. E. (1997) · Clinical Microbiology Reviews · doi:10.1128/cmr.10.1.1 · Cited by 577
Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide
Minghetti, L. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00052-x · Cited by 567
Mammalian Nitric Oxide Synthases
Stuehr, D. J., & Griffith, O. W. (1992) · Advances in Enzymology - and Related Areas of Molecular Biology · doi:10.1002/9780470123119.ch8 · Cited by 508
Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation
Mannick, J. B., Asano, K., Izumi, K., Kieff, E., & Stamler, J. S. (1994) · Cell · doi:10.1016/0092-8674(94)90005-1 · Cited by 501
Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis.
Nicholson, S., Bonecini-Almeida, M. D. G., Lapa e Silva, J. R., Nathan, C., Xie, Q. W., Mumford, R., Weidner, J. R., Calaycay, J., Geng, J., Boechat, N., et al. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.5.2293 · Cited by 496
Hibbs, J. B., Westenfelder, C., Taintor, R., Vavrin, Z., Kablitz, C., Baranowski, R. L., Ward, J. H., Menlove, R. L., McMurry, M. P., & Kushner, J. P. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115666 · Cited by 485
In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases.
Koprowski, H., Zheng, Y. M., Heber-Katz, E., Fraser, N., Rorke, L., Fu, Z. F., Hanlon, C., & Dietzschold, B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.7.3024 · Cited by 474
Weinberg, J., Misukonis, M., Shami, P., Mason, S., Sauls, D., Dittman, W., Wood, E., Smith, G., McDonald, B., & Bachus, K. (1995) · Blood · doi:10.1182/blood.v86.3.1184.1184 · Cited by 440
Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin
Nussler, A. K., Di Silvio, M., Billiar, T. R., Hoffman, R. A., Geller, D. A., Selby, R., Madariaga, J., & Simmons, R. L. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.176.1.261 · Cited by 420
Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides.
Sakurai, H., Kohsaka, H., Liu, M. F., Higashiyama, H., Hirata, Y., Kanno, K., Saito, I., & Miyasaka, N. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118292 · Cited by 387
Cross, A. H., Misko, T. P., Lin, R. F., Hickey, W. F., Trotter, J. L., & Tilton, R. G. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117282 · Cited by 384
Rosenkranz-Weiss, P., Sessa, W. C., Milstien, S., Kaufman, S., Watson, C. A., & Pober, J. S. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117221 · Cited by 362
NO Inhibitions: Antimicrobial Properties of Nitric Oxide
De Groote, M. A., & Fang, F. C. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.supplement_2.s162 · Cited by 358
Induction of nitric oxide synthase activity in human astrocytes by interleukin-1β and interferon-γ
Lee, S. C., Dickson, D. W., Liu, W., & Brosnan, C. F. (1993) · Journal of Neuroimmunology · doi:10.1016/0165-5728(93)90229-r · Cited by 354
Nitric Oxide in the Vasculature: Physiology and Pathophysiology
MONCADA, S. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb51989.x · Cited by 340
Meydani, S. N., & Ha, W.-K. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.4.861 · Cited by 337
Schneemann, M., Schoedon, G., Hofer, S., Blau, N., Guerrero, L., & Schaffner, A. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/167.6.1358 · Cited by 333
Liew, F. Y., & O'Donnell, C. A. (1993) · Advances in Parasitology · doi:10.1016/s0065-308x(08)60208-0 · Cited by 332
Immunopathology of tuberculosis: roles of macrophages and monocytes
Fenton, M. J., & Vermeulen, M. W. (1996) · Infection and Immunity · doi:10.1128/iai.64.3.683-690.1996 · Cited by 306
Antimicrobial mechanisms of fish phagocytes and their role in host defense
Neumann, N. F., Stafford, J. L., Barreda, D., Ainsworth, A. J., & Belosevic, M. (2001) · Developmental & Comparative Immunology · doi:10.1016/s0145-305x(01)00037-4 · Cited by 303
Role of nitric oxide in tumour progression: Lessons from human tumours
Thomsen, L. L., & Miles, D. W. (1998) · Cancer and Metastasis Reviews · doi:10.1023/a:1005912906436 · Cited by 276
Human monocytes/macrophages: NO or no NO?
Denis, M. (1994) · Journal of Leukocyte Biology · doi:10.1002/jlb.55.5.682 · Cited by 274
Self-citationVouldoukis, I., Riveros-Moreno, V, Dugas, B., Ouaaz, F., Bécherel, P., Debré, P., Moncada, S., & Mossalayi, M. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7804 · Cited by 267
Nitric Oxide in Macrophage Immunometabolism: Hiding in Plain Sight
Palmieri, E. M., McGinity, C., Wink, D. A., & McVicar, D. W. (2020) · Metabolites · doi:10.3390/metabo10110429 · Cited by 237
On the expression of nitric oxide synthase by human macrophages. Why no NO?
Albina, J. E. (1995) · Journal of Leukocyte Biology · doi:10.1002/jlb.58.6.643 · Cited by 213
Iron: Mammalian defense systems, mechanisms of disease, and chelation therapy approaches
Kontoghiorghes, G. J., & Weinberg, E. D. (1995) · Blood Reviews · doi:10.1016/0268-960x(95)90038-1 · Cited by 134
Nitric oxide and inflammatory arthritides
Miyasaka, N., & Hirata, Y. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00585-7 · Cited by 93
Lectin-Induced Nitric Oxide Production
Andrade, J. L., Arruda, S., Barbosa, T., Paim, L., Ramos, M. V., Cavada, B. S., & Barral-Netto, M. (1999) · Cellular Immunology · doi:10.1006/cimm.1999.1494 · Cited by 86
Metadata
- Authors
- Denis, M.
- Venue
- Journal of Leukocyte Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 1991-04-01
- Volume
- 49
- Issue
- 4
- Pages
- 380-387
- ISSN
- 0741-5400 (ISSN-L)
- 1938-3673
- OpenAlex
- W2187116198
- Cited by
- 384
- References
- 23
- FWCI
- 35.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.